Načítá se...
Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression
OBJECTIVES: We conducted a systematic review and meta-analysis with meta-regression of creatine kinase-MB (CK-MB), a biomarker of myocardial injury, in COVID-19 patients. METHODS: We searched PubMed, Web of Science and Scopus, for studies published between January 2020 and January 2021 that reported...
Uloženo v:
| Vydáno v: | Adv Med Sci |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medical University of Bialystok. Published by Elsevier B.V.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8260505/ https://ncbi.nlm.nih.gov/pubmed/34256241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.advms.2021.07.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|